Kohjin Bio splits chair and president roles, adopts audit-committee structure
The move: Kohjin Bio’s shareholders approved an audit and supervisory committee structure, split the top jobs between a chair and president, and signed off on a ¥10 per share dividend worth ¥51.1mn. Separately, Takahito Nakamura remained disclosed as the controlling shareholder with 53.91% of voting rights.